Published in Ann Oncol on May 05, 2010
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol (2011) 13.95
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. Lancet (2010) 5.04
Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acid. JAMA Intern Med (2014) 2.20
St. Gallen 2011: Summary of the Consensus Discussion. Breast Care (Basel) (2011) 1.62
Adjuvant therapy with zoledronic acid in patients with breast cancer: a systematic review and meta-analysis. Oncologist (2013) 1.54
Anti-tumour strategies aiming to target tumour-associated macrophages. Immunology (2013) 1.40
Future directions of bone-targeted therapy for metastatic breast cancer. Nat Rev Clin Oncol (2010) 1.27
Prognostic factors for patients with bone-only metastasis in breast cancer. Yonsei Med J (2013) 1.18
Exposure to oral bisphosphonates and risk of cancer. Int J Cancer (2012) 1.17
Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst (2011) 1.08
Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper. Osteoporos Int (2012) 1.05
Anti-tumour activity of bisphosphonates in preclinical models of breast cancer. Breast Cancer Res (2010) 1.04
Statin use in primary inflammatory breast cancer: a cohort study. Br J Cancer (2013) 1.00
Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients. Clin Interv Aging (2012) 0.98
The enhancement of radiosensitivity in human esophageal squamous cell carcinoma cells by zoledronic acid and its potential mechanism. Cytotechnology (2013) 0.97
Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial. BMC Cancer (2013) 0.95
Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells. Cancer Immunol Immunother (2012) 0.95
Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid. Cancer Biol Ther (2012) 0.93
Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years? J Transl Med (2013) 0.92
Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor. Breast Care (Basel) (2010) 0.92
Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy. NPJ Breast Cancer (2016) 0.92
Zoledronic acid as an adjuvant therapy in patients with breast cancer: a systematic review and meta-analysis. PLoS One (2012) 0.91
Targeting tumor-infiltrating macrophages to combat cancer. Immunotherapy (2013) 0.91
Increased fracture rate in women with breast cancer: a review of the hidden risk. BMC Cancer (2011) 0.91
Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay. BMC Cancer (2012) 0.89
A Study of Zoledronic Acid as Neo-Adjuvant, Perioperative Therapy in Patients with Resectable Pancreatic Ductal Adenocarcinoma. J Cancer Ther (2013) 0.88
Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer. Clin Cancer Res (2011) 0.88
Bisphosphonates and their Role in Therapy for Breast Cancer - Results from the PATH Biobank. Geburtshilfe Frauenheilkd (2013) 0.88
Zoledronic acid inhibits aromatase activity and phosphorylation: potential mechanism for additive zoledronic acid and letrozole drug interaction. J Steroid Biochem Mol Biol (2012) 0.88
Breast Cancer: Rank Ligand Inhibition. Breast Care (Basel) (2010) 0.88
Zoledronic acid in breast cancer: latest findings and interpretations. Ther Adv Med Oncol (2011) 0.87
Medication-induced osteoporosis: screening and treatment strategies. Ther Adv Musculoskelet Dis (2014) 0.87
Adjuvant systemic therapy in older women with breast cancer. Breast Cancer (Dove Med Press) (2016) 0.85
Aromatase inhibitors for the treatment of endometriosis. Fertil Steril (2012) 0.85
Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer. Br J Cancer (2012) 0.85
Bisphosphonates in the adjuvant setting of breast cancer therapy--effect on survival: a systematic review and meta-analysis. PLoS One (2013) 0.84
Retracted Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene. Expert Opin Pharmacother (2011) 0.83
Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment? Breast Cancer Res (2012) 0.83
Optimal management of bone metastases in breast cancer patients. Breast Cancer (Dove Med Press) (2011) 0.83
Evaluation of dental implants as a risk factor for the development of bisphosphonate-related osteonecrosis of the jaw in breast cancer patients. Odontology (2015) 0.81
Innegligible musculoskeletal disorders caused by zoledronic acid in adjuvant breast cancer treatment: a meta-analysis. J Exp Clin Cancer Res (2011) 0.81
Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases. Cancer (2011) 0.81
Role of zoledronate in aromatase activity should be considered in future studies. Oncologist (2013) 0.81
Zoledronic acid reverses the epithelial-mesenchymal transition and inhibits self-renewal of breast cancer cells through inactivation of NF-κB. Mol Cancer Ther (2013) 0.81
Prevention of bone metastases and management of bone health in early breast cancer. Breast Cancer Res (2010) 0.81
Analysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vδ2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate. Cancer Prev Res (Phila) (2016) 0.81
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients. BMC Cancer (2014) 0.80
Preventive effect of risedronate on bone loss and frailty fractures in elderly women treated with anastrozole for early breast cancer. J Bone Miner Metab (2011) 0.80
Early-Stage Breast Cancer in the Elderly: Confronting an Old Clinical Problem. J Breast Cancer (2015) 0.80
Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma. Br J Cancer (2015) 0.80
Adjuvant therapy with zoledronic Acid and menopausal status. Oncologist (2013) 0.80
Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumab. Clin Med Insights Oncol (2012) 0.79
Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion. Ther Adv Med Oncol (2011) 0.79
Randomized clinical trial of zoledronic acid in multiple myeloma patients undergoing high-dose chemotherapy and stem-cell transplantation. Curr Oncol (2013) 0.79
The role of the bone microenvironment in skeletal metastasis. J Bone Oncol (2012) 0.79
Effect of adjuvant bisphosphonates on disease-free survival in early breast cancer: Retrospective analysis results in an unselected single-center cohort. J Bone Oncol (2013) 0.78
Aromatase inhibitors-induced bone loss in early breast cancer. Bonekey Rep (2012) 0.78
Novel immunostimulatory effects of osteoclasts and macrophages on human γδ T cells. Bone (2014) 0.77
Assessment of general characteristics of patients with primary metastatic breast carcinoma: single center experience. Contemp Oncol (Pozn) (2013) 0.77
Skeletal manifestations of treatment of breast cancer. Curr Osteoporos Rep (2013) 0.77
Patterns of bone density evaluation in a community population treated with aromatase inhibitors. Breast Cancer Res Treat (2012) 0.77
Possible anti-tumor activity of initial treatment with zoledronic acid with hormonal therapy for bone-metastatic prostate cancer in multicenter clinical trial. Int J Clin Oncol (2012) 0.77
Pathophysiology of Bone Remodelling and Current Therapeutic Approaches. Geburtshilfe Frauenheilkd (2012) 0.77
Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot study. Prostate Int (2014) 0.76
Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid. Int J Womens Health (2012) 0.76
Prevention of anastrozole induced bone loss with monthly oral ibandronate: Final 5 year results from the ARIBON trial. J Bone Oncol (2012) 0.76
Targeted therapies: adjuvant bisphosphonates--an option with low estrogen? Nat Rev Clin Oncol (2011) 0.76
A meta-analysis of the antitumor effect and safety of bisphosphonates in the treatment of multiple myeloma. Int J Clin Exp Med (2015) 0.76
Importance of antiresorptive therapies for patients with bone metastases from solid tumors. Cancer Manag Res (2012) 0.76
Bone-Targeted Therapy. Geburtshilfe Frauenheilkd (2015) 0.75
Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer. Breast Cancer (Dove Med Press) (2011) 0.75
Effects of modified Shu-Gan-Liang-Xue decoction combined with anastrozole on osteoblastic proliferation and differentiation of MC3T3-E1 cells. Mol Med Rep (2014) 0.75
Bone Health in Patients with Breast Cancer: Recommendations from an Evidence-Based Canadian Guideline. J Clin Med (2013) 0.75
A virtual approach to evaluate therapies for management of multiple myeloma induced bone disease. Int J Numer Method Biomed Eng (2015) 0.75
Management of Potential Long-Term Toxicities in Breast Cancer Patients. Curr Breast Cancer Rep (2016) 0.75
Decreased risk of breast cancer associated with oral bisphosphonate therapy. Breast Cancer (Dove Med Press) (2012) 0.75
Prevention and Treatment of Bone Metastases in Breast Cancer. J Clin Med (2013) 0.75
Prevention of Bone Metastases in Breast Cancer Patients. Therapeutic Perspectives. J Clin Med (2014) 0.75
Bisphosphonates as potential adjuvants for patients with cancers of the digestive system. World J Gastroenterol (2016) 0.75
Preclinical evaluation of sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastases. BMC Cancer (2013) 0.75
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. J Bone Oncol (2017) 0.75
AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011. Breast Care (Basel) (2011) 0.75
Management options of breast cancer related osteoporosis. Clin Cases Miner Bone Metab (2014) 0.75
The effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeleton. PLoS One (2014) 0.75
Management of bone health in postmenopausal women on aromatase inhibitors (AIs): a single health care system experience. Support Care Cancer (2017) 0.75
Bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer. Eur J Orthop Surg Traumatol (2013) 0.75
Kinetics of renaturation of DNA. J Mol Biol (1968) 25.41
Methylmercury as a reversible denaturing agent for agarose gel electrophoresis. Anal Biochem (1976) 21.07
Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J (1985) 20.39
Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. I. Structure of F-prime factors. J Mol Biol (1972) 19.88
Rates of formation and thermal stabilities of RNA:DNA and DNA:DNA duplexes at high concentrations of formamide. Nucleic Acids Res (1977) 15.92
Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med (2013) 13.90
Mutations in the p53 gene occur in diverse human tumour types. Nature (1989) 13.62
A physical map of 30,000 human genes. Science (1998) 12.43
The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med (2001) 11.48
Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. II. Structure of drug resistance (R) factors and F factors. J Mol Biol (1973) 11.40
A new system for grading recommendations in evidence based guidelines. BMJ (2001) 11.13
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science (2001) 9.09
Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest (1996) 7.97
A comprehensive genetic map of the mouse genome. Nature (1996) 6.94
A physical study by electron microscopy of the terminally reptitious, circularly permuted DNA from the coliphage particles of Escherichia coli 15. J Mol Biol (1970) 6.63
The actin genes of Drosophila: a dispersed multigene family. Cell (1980) 5.91
Transcripts of the six Drosophila actin genes accumulate in a stage- and tissue-specific manner. Cell (1983) 5.44
Electron microscope heteroduplex studies of sequence relations among bacterial plasmids: identification and mapping of the insertion sequences IS1 and IS2 in F and R plasmids. J Bacteriol (1975) 5.44
Multi-system neurological disease is common in patients with OPA1 mutations. Brain (2010) 5.37
The actin genes of Drosophila: protein coding regions are highly conserved but intron positions are not. Cell (1981) 5.27
A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science (1991) 5.14
A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature (1988) 5.11
Covalently closed circular DNA of avian sarcoma virus: purification from nuclei of infected quail tumor cells and measurement by electron microscopy and gel electrophoresis. J Mol Biol (1976) 4.65
Effects of a decision support system on the diagnostic accuracy of users: a preliminary report. J Am Med Inform Assoc (1997) 4.61
Mapping of poly(A) sequences in the electron microscope reveals unusual structure of type C oncornavirus RNA molecules. Cell (1976) 4.41
IS2, a genetic element for turn-off and turn-on of gene activity in E. coli. Mol Gen Genet (1974) 4.16
Interspersion of repetitive and nonrepetitive DNA sequences in the Drosophila melanogaster genome. Cell (1975) 4.13
Hydrodynamic shear breakage of DNA. Biopolymers (1972) 4.12
Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet (1972) 3.90
On the probability of ring closure of lambda DNA. J Mol Biol (1966) 3.82
The inducible lac operator-repressor system is functional in mammalian cells. Cell (1987) 3.80
Thermodynamic and kinetic studies on the interconversion between the linear and circular forms of phage lambda DNA. J Mol Biol (1966) 3.76
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet (2005) 3.75
Improved methods for the formation and stabilization of R-loops. Nucleic Acids Res (1979) 3.73
Health literacy and health-related knowledge among persons living with HIV/AIDS. Am J Prev Med (2000) 3.70
Drosophila has one myosin heavy-chain gene with three developmentally regulated transcripts. Cell (1983) 3.69
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. J Clin Oncol (1997) 3.61
Expression of the mitochondrial genome in HeLa cells. VI. Size determination of mitochondrial ribosomal RNA by electron microscopy. J Mol Biol (1971) 3.57
A rat brain Na+ channel alpha subunit with novel gating properties. Neuron (1988) 3.48
Cuticle protein genes of Drosophila: structure, organization and evolution of four clustered genes. Cell (1982) 3.48
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study. Ann Oncol (2001) 3.44
Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest (1995) 3.43
Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis (2001) 3.36
Electron-microscopic visualization of deletion mutations. Proc Natl Acad Sci U S A (1968) 3.35
Sequence arrangement of the rDNA of Drosophila melanogaster. Cell (1977) 3.35
Divided attention: evidence for coactivation with redundant signals. Cogn Psychol (1982) 3.28
Intercellular Communication: Renal, Urinary Bladder, Sensory, and Salivary Gland Cells. Science (1965) 3.28
The inward rectifier potassium channel family. Curr Opin Neurobiol (1995) 3.23
RD-114, baboon, and woolly monkey viral RNA's compared in size and structure. Cell (1976) 3.20
Immunoglobulin heavy chain gene organization in mice: analysis of a myeloma genomic clone containing variable and alpha constant regions. Proc Natl Acad Sci U S A (1979) 3.19
Steady states, charge movements, and rates for a cloned GABA transporter expressed in Xenopus oocytes. Neuron (1993) 3.10
Cloning and expression of a rat brain GABA transporter. Science (1990) 3.08
CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet (1995) 3.07
An electron microscope study of Sindbis virus RNA. Cold Spring Harb Symp Quant Biol (1974) 2.99
Genetic studies of the Lac repressor. XV: 4000 single amino acid substitutions and analysis of the resulting phenotypes on the basis of the protein structure. J Mol Biol (1996) 2.98
A heteroduplex study of the sequence relationships between the RNAs of M-MSV and M-MLV. Cell (1977) 2.96
High-molecular-weight RNAs of AKR, NZB, and wild mouse viruses and avian reticuloendotheliosis virus all have similar dimer structures. J Virol (1978) 2.96
A new method of in situ hybridization. Chromosoma (1975) 2.94
Electron microscope heteroduplex study of sequence relations of T2, T4, and T6 bacteriophage DNAs. Virology (1974) 2.82
Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate. J Clin Oncol (2001) 2.81
Heteroduplex analysis of the sequence relations between the RNAs of mink cell focus-inducing and murine leukemia viruses. J Virol (1978) 2.79
Electron microscope heteroduplex study of the heterogeneity of Mu phage and prophage DNA. Virology (1974) 2.72
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet (2015) 2.70
Integrating a modern knowledge-based system architecture with a legacy VA database: the ATHENA and EON projects at Stanford. Proc AMIA Symp (1999) 2.68
Structure, subunit composition, and molecular weight of RD-114 RNA. J Virol (1975) 2.66
Selective dissociation of histones from calf thymus nucleoprotein. J Mol Biol (1967) 2.65
Electron microscopic heteroduplex studies of sequence relations among plasmids of Escherichia coli: structure of F13 and related F-primes. J Bacteriol (1975) 2.60
Heteroduplex analysis of avian RNA tumor viruses. Proc Natl Acad Sci U S A (1977) 2.59
Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial. Ann Oncol (2013) 2.57
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J Exp Med (1986) 2.55
A radiation hybrid map of the rat genome containing 5,255 markers. Nat Genet (1999) 2.54
The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO). Ann Oncol (2013) 2.53
Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis (2001) 2.52
Heteroduplex structures of bacteriophage Mu DNA. Virology (1973) 2.52
Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst (1996) 2.51
Identification of the class I genes of the mouse major histocompatibility complex by DNA-mediated gene transfer. Nature (1982) 2.48
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation (1997) 2.46
The long-term reproductive health consequences of female genital cutting in rural Gambia: a community-based survey. Trop Med Int Health (2001) 2.45
RGS proteins reconstitute the rapid gating kinetics of gbetagamma-activated inwardly rectifying K+ channels. Proc Natl Acad Sci U S A (1997) 2.43
Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. BMJ (1996) 2.43
Effect of DNA length on the free energy of binding of an unwinding ligand to a supercoiled DNA. J Mol Biol (1972) 2.40
Prolonged expiratory apnoea: a disorder resulting in episodes of severe arterial hypoxaemia in infants and young children. Lancet (1985) 2.36
Diffusion tensor imaging of normal and injured developing human brain - a technical review. NMR Biomed (2002) 2.36
A neutral amino acid change in segment IIS4 dramatically alters the gating properties of the voltage-dependent sodium channel. Proc Natl Acad Sci U S A (1990) 2.35
Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215. J Virol (1997) 2.32
Evidence that the M2 membrane-spanning region lines the ion channel pore of the nicotinic receptor. Science (1988) 2.31
Strength of the cement-bone interface. Clin Orthop Relat Res (1982) 2.31
An open randomised trial of second-line endocrine therapy in advanced breast cancer. comparison of the aromatase inhibitors letrozole and anastrozole. Eur J Cancer (2003) 2.31
Triggered correlation. IEEE Trans Biomed Eng (1968) 2.30
Electron microscope studies of tumor virus RNA. Cold Spring Harb Symp Quant Biol (1975) 2.30
Electron microscope studies of heteroduplex DNA from a deletion mutant of bacteriophage phiX-174. Proc Natl Acad Sci U S A (1972) 2.29
Isolation and characterization of the human pulmonary surfactant apoprotein gene. Nature (1985) 2.27
A-type potassium channels expressed from Shaker locus cDNA. Proc Natl Acad Sci U S A (1988) 2.26
Electron microscopic visualization of tRNA genes with ferritin-avidin: biotin labels. Nucleic Acids Res (1978) 2.24
Southern Ocean frontal structure and sea-ice formation rates revealed by elephant seals. Proc Natl Acad Sci U S A (2008) 2.24